Skip to main content
  • Saved

Commented on 's Post

A trial of antithrombotic therapy in patients with refractory migraine and antiphospholipid antibodies: A retrospective study of 75 patients.

A trial of antithrombotic therapy in patients with refractory migraine and antiphospholipid antibodies: A retrospective study of 75 patients.

Source :

https://read.qxmd.com/read/33402037/a-trial-of-antithrombotic-therapy-in-patients-with-refractory-migraine-and-antiphospholipid-antibodies-a-retrospective-study-of-75-patients

OBJECTIVE: It has been reported that patients with antiphospholipid antibodies (aPL) and refractory migraine may experience symptomatic improvement with antithrombotic therapy, but this phenomenon has not been well studied. This study was undertaken to detail the response to trials of antithrombotic therapy in these patients.

  • 5 days 23 hours
    It is possible that there is a level of microthrombi causing migraine in these patients. Will need more follow up studies.